IMUX
Income statement / Annual
Last year (2024), Immunic, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Immunic, Inc.'s net income was -$100.51 M.
See Immunic, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$6.32 K |
$0.00 |
| Cost of Revenue |
$0.00
|
$111.00 K
|
$77.00 K
|
$85.00 K
|
$39.00 K
|
$50.00 K
|
$15.00 K
|
$998.00 K
|
$1.81 M
|
$1.33 M
|
| Gross Profit |
$0.00
|
-$111.00 K
|
-$77.00 K
|
-$85.00 K
|
-$39.00 K
|
-$50.00 K
|
-$15.00 K
|
-$998.00 K
|
-$1.80 M
|
-$1.33 M
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-285.3
|
0
|
| Research and Development Expenses |
$80.05 M
|
$83.22 M
|
$71.26 M
|
$61.12 M
|
$38.64 M
|
$22.51 M
|
$24.83 M
|
$39.34 M
|
$30.05 M
|
$39.77 M
|
| General & Administrative Expenses |
$18.01 M
|
$16.01 M
|
$15.26 M
|
$13.30 M
|
$10.33 M
|
$14.52 M
|
$13.59 M
|
$13.31 M
|
$11.22 M
|
$12.35 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$18.01 M
|
$16.01 M
|
$15.26 M
|
$13.30 M
|
$10.33 M
|
$14.52 M
|
$13.59 M
|
$13.31 M
|
$11.22 M
|
$12.35 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$1.96 M
|
$17.25 M
|
$4.90 M
|
$1.99 M
|
$28.00 K
|
$0.00
|
$297.00 K
|
$97.00 K
|
| Operating Expenses |
$98.05 M
|
$99.22 M
|
$86.52 M
|
$91.67 M
|
$48.97 M
|
$37.03 M
|
$38.41 M
|
$52.66 M
|
$41.27 M
|
$52.12 M
|
| Cost And Expenses |
$0.00
|
$99.22 M
|
$86.52 M
|
$91.67 M
|
$48.97 M
|
$37.03 M
|
$38.41 M
|
$52.66 M
|
$41.27 M
|
$52.12 M
|
| Interest Income |
$3.39 M
|
$3.08 M
|
$1.04 M
|
$66.00 K
|
$58.00 K
|
$107.00 K
|
$521.00 K
|
$650.00 K
|
$284.00 K
|
$58.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$1.04 M
|
$0.00
|
$0.00
|
$107.00 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$111.00 K
|
$77.00 K
|
$85.00 K
|
$39.00 K
|
$50.00 K
|
$15.00 K
|
$998.00 K
|
$1.81 M
|
$1.33 M
|
| EBITDA |
-$100.37 M |
-$99.11 M |
-$120.33 M |
-$92.86 M |
-$48.93 M |
-$36.98 M |
-$15.14 M |
-$51.08 M |
-$39.16 M |
-$50.70 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-6201.15
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-6534.48
|
0
|
| Total Other Income/Expenses Net |
-$2.46 M
|
$5.61 M
|
-$919.00 K
|
-$1.28 M
|
$4.95 M
|
$2.10 M
|
$455.00 K
|
$577.00 K
|
$297.00 K
|
$97.00 K
|
| Income Before Tax |
-$100.51 M
|
-$93.61 M
|
-$120.41 M
|
-$92.95 M
|
-$44.02 M
|
-$34.93 M
|
-$41.48 M
|
-$52.08 M
|
-$40.97 M
|
-$52.02 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-6487.45
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$33.89 M
|
-$151.00 K
|
-$58.00 K
|
-$107.00 K
|
$549.00 K
|
-$577.00 K
|
-$1.81 M
|
-$1.33 M
|
| Net Income |
-$100.51 M
|
-$93.61 M
|
-$154.30 M
|
-$92.79 M
|
-$43.96 M
|
-$34.83 M
|
-$41.48 M
|
-$52.08 M
|
-$40.97 M
|
-$52.02 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
-6487.45
|
0
|
| EPS |
-1 |
-2.11 |
-4.85 |
-3.92 |
-2.81 |
-4.51 |
-39.16 |
-52.26 |
-52.21 |
-82.73 |
| EPS Diluted |
-1 |
-2.11 |
-4.85 |
-3.92 |
-2.81 |
-4.51 |
-39.16 |
-52.26 |
-52.21 |
-82.73 |
| Weighted Average Shares Out |
$100.17 M
|
$44.32 M
|
$31.82 M
|
$23.65 M
|
$15.66 M
|
$7.72 M
|
$1.06 M
|
$996.48 K
|
$784.69 K
|
$628.82 K
|
| Weighted Average Shares Out Diluted |
$100.17 M
|
$44.32 M
|
$31.82 M
|
$23.65 M
|
$15.66 M
|
$7.72 M
|
$1.06 M
|
$996.48 K
|
$784.69 K
|
$628.82 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
